1. abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración
  2. Track

abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración

Primary tabs

Time ReferrerUserOperations
07/10/2025 - 10:40node/7427/trackAnonymous (not verified)details
07/10/2025 - 10:23node/7427/trackAnonymous (not verified)details
07/10/2025 - 09:39node/7427/trackAnonymous (not verified)details
07/10/2025 - 09:32node/7427/trackAnonymous (not verified)details
07/10/2025 - 08:58node/7427/trackAnonymous (not verified)details
07/10/2025 - 08:58node/7427/trackAnonymous (not verified)details
07/10/2025 - 08:52node/7427/trackAnonymous (not verified)details
07/10/2025 - 07:30node/7427/trackAnonymous (not verified)details
07/10/2025 - 04:17node/7427/trackAnonymous (not verified)details
07/10/2025 - 04:17node/7427/trackAnonymous (not verified)details
07/10/2025 - 04:16node/7427/trackAnonymous (not verified)details
07/10/2025 - 04:16node/7427/trackAnonymous (not verified)details
07/10/2025 - 04:16node/7427/trackAnonymous (not verified)details
07/10/2025 - 04:16node/7427/trackAnonymous (not verified)details